OXIMERAM SL 1500
OXIMERAM SL 1500
(Meropenem & Sulbactam for Injection)
n
Composition:
nEach vial contains:
n
nMeropenem                                           I.P.
n
nEq. to Anhydrous Meropenem                         1000 mg
n
nSodium Carbonate (Anhydrous)Â Â Â Â Â Â Â Â Â I.P.
n
nEq. to Sodium (As Buffer)Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 90.2 mg
n
nSulbactam Sodium                                I.P.
n
nEq. to Sulbactam                                                  500 mg
n
Packaging:
nVial + 20 ml WFI
Product Description
OXIMERAM SL 1500 is a broad-spectrum antibacterial injection containing Meropenem 1000 mg and Sulbactam 500 mg, formulated for the treatment of severe and complicated bacterial infections.
n
nMeropenem, a carbapenem antibiotic, acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), resulting in rapid bactericidal activity. Sulbactam functions as a β-lactamase inhibitor, protecting meropenem from enzymatic degradation and enhancing its efficacy against resistant pathogens. This synergistic combination provides extended coverage against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, making it suitable for managing serious hospital-acquired and multidrug-resistant infections.
n
nOXIMERAM SL 1500 is indicated for respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, meningitis, and other severe systemic infections.
n
Indications:
n
-
n
- Severe respiratory tract infections (pneumonia, bronchopneumonia)
- Skin and soft tissue infections
- Intra-abdominal (stomach) infections
- Urinary tract infections (UTIs)
- Septicemia and blood infections
- Bacterial meningitis and other brain infections
- Gynecological infections
- Bone and joint infections
- Complicated or multidrug-resistant bacterial infections
n
n
n
n
n
n
n
n
n
n
Therapeutic Segment Positioning:
nAntibiotic
